Obesity modifies the performance of fibrosis biomarkers in nonalcoholic fatty liver disease
S Qadri, N Ahlholm, I Lønsmann… - The Journal of …, 2022 - academic.oup.com
Context Guidelines recommend blood-based fibrosis biomarkers to identify advanced
nonalcoholic fatty liver disease (NAFLD), which is particularly prevalent in patients with …
nonalcoholic fatty liver disease (NAFLD), which is particularly prevalent in patients with …
Performance of non-invasive fibrosis scores in non-alcoholic fatty liver disease with and without morbid obesity
A Drolz, S Wolter, MH Wehmeyer, F Piecha… - International journal of …, 2021 - nature.com
Background Non-invasive scores, such as the non-alcoholic fatty liver disease (NAFLD)
Fibrosis Score (NFS), are increasingly used for liver fibrosis assessment in patients with …
Fibrosis Score (NFS), are increasingly used for liver fibrosis assessment in patients with …
Identifying nonalcoholic fatty liver disease advanced fibrosis in the veterans health administration
YA Patel, EJ Gifford, LM Glass, MJ Turner… - Digestive diseases and …, 2018 - Springer
Background Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic
liver disease. Severe NAFLD with advanced fibrosis results in substantial morbidity and …
liver disease. Severe NAFLD with advanced fibrosis results in substantial morbidity and …
Accuracy of Fibrosis-4 index and non-alcoholic fatty liver disease fibrosis scores in metabolic (dysfunction) associated fatty liver disease according to body mass index …
Methods A total of 560 patients (28 lean, 174 overweight, 229 obese, 89 severely obese, 40
morbidly obese) were included. Diagnostic performances and optimal cut-off values for FIB …
morbidly obese) were included. Diagnostic performances and optimal cut-off values for FIB …
Diagnostic performance of the fibrosis-4 Index and nonalcoholic fatty liver disease fibrosis score in lean adults with nonalcoholic fatty liver disease
H Park, EL Yoon, T Ito, AJ Jo, M Kim, J Lee… - JAMA Network …, 2023 - jamanetwork.com
IMPORTANCE The diagnostic performance of the fibrosis-4 index (FIB-4) and nonalcoholic
fatty liver disease (NAFLD) fibrosis score (NFS) for advanced fibrosis in lean patients with …
fatty liver disease (NAFLD) fibrosis score (NFS) for advanced fibrosis in lean patients with …
[HTML][HTML] Validation of non-invasive fibrosis scores for predicting advanced fibrosis in metabolic-associated fatty liver disease
X Chen, GBB Goh, J Huang, Y Wu… - Journal of Clinical …, 2022 - ncbi.nlm.nih.gov
Methods The NHANES 2017-2018 datasets were used to compare the performances of
different noninvasive fibrosis scores in MAFLD, including the aspartate aminotransferase …
different noninvasive fibrosis scores in MAFLD, including the aspartate aminotransferase …
Development and validation of hepamet fibrosis scoring system–a simple, noninvasive test to identify patients with nonalcoholic fatty liver disease with advanced …
J Ampuero, R Pais, R Aller, R Gallego-Durán… - Clinical …, 2020 - Elsevier
Background & Aims Fibrosis affects prognoses for patients with nonalcoholic fatty liver
disease (NAFLD). Several non-invasive scoring systems have aimed to identify patients at …
disease (NAFLD). Several non-invasive scoring systems have aimed to identify patients at …
A pragmatic approach identifies a high rate of nonalcoholic fatty liver disease with advanced fibrosis in diabetes clinics and at‐risk populations in primary care
PJ Patel, F Hossain, LU Horsfall, X Banh… - Hepatology …, 2018 - journals.lww.com
Noninvasive serum biomarkers (nonalcoholic fatty liver disease fibrosis score [NFS], fibrosis
4 score [FIB‐4], or enhanced liver fibrosis [ELF] test) are recommended as first‐line tools to …
4 score [FIB‐4], or enhanced liver fibrosis [ELF] test) are recommended as first‐line tools to …
Comparison of diagnostic performance between FIB‐4 and NFS in metabolic‐associated fatty liver disease era
H Park, EL Yoon, M Kim, J Lee, JH Kim… - Hepatology …, 2022 - Wiley Online Library
Abstract Aims Fibrosis‐4 index (FIB‐4) and non‐alcoholic fatty liver disease (NAFLD)
fibrosis score (NFS) are the two most widely used non‐invasive tools for screening of …
fibrosis score (NFS) are the two most widely used non‐invasive tools for screening of …
Individualized risk prediction of significant fibrosis in non-alcoholic fatty liver disease using a novel nomogram
YJ Zhou, FZ Ye, YY Li, XY Pan… - United European …, 2019 - journals.sagepub.com
Background Fibrosis is deemed to be a pivotal determinant of the long-term prognosis in
non-alcoholic fatty liver disease (NAFLD). Objective We aimed to develop a novel …
non-alcoholic fatty liver disease (NAFLD). Objective We aimed to develop a novel …